NP Thyroid 60
- Product NDC
- 82804-325
- Requested package NDC
- 82804-325-72
- 11-digit product format
- 828040325
- Labeler code
- 82804
- Product ID
- 82804-325_63d9fd60-779a-4589-9977-4441c855574f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LEVOTHYROXINE, LIOTHYRONINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2010-11-11
- Substance
- LEVOTHYROXINE; LIOTHYRONINE
- Active strength
- 38; 9 ug/1; ug/1
- Pharmacologic classes
- Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NP Thyroid 60
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE | 38 ug/1 |
| LIOTHYRONINE | 9 ug/1 |
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| Q51BO43MG4 | Internal UNII lookup |
| 06LU7C9H1V | Internal UNII lookup |
Harmonized RxCUI identifiers#
RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 313391 | Internal RxNorm lookup |
| 1724481 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82804-325-72 | 82804032572 | 120 TABLET in 1 BOTTLE (82804-325-72) | 120 tablet | 2026-10-27 | No | No | Current |